This review summarizes our current knowledge on bone metabolism in PwO treated by GLP-1Ra
This medication is approved for use in individuals who meet specific medical criteria, including a certain body mass index (BMI) threshold and the presence of weight-related health conditions
If you're still in dose escalation (moving from 0.25 mg to 0.5 mg to 1.0 mg, etc.), taking a dose early essentially acts like a smaller dose increase, potentially triggering breakthrough hunger or inconsistent appetite control
In this guide, we break down what the research actually supports, where inositol appears most useful, and which supplements best reflect the evidence
Cerebral micro-vessels are able to use both glucose and FAs as energy sources, a process seemingly driven by nutrient availability (Hingorani and Brecher, 1987)
IMPORTANT NOTE: This situation is quickly and constantly changing and will likely continue to do so